Ignite Creation Date:
2024-05-06 @ 3:58 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02415413
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-09-10
First Post:
2015-03-29
Brief Title:
Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma
Sponsor:
PETHEMA Foundation
Organization:
PETHEMA Foundation
Organization Data
Organization:
PETHEMA Foundation
Class:
OTHER
Study ID:
GEM-CESAR
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
PETHEMA Foundation
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Amgen | INDUSTRY |
| Celgene Corporation | INDUSTRY |